Emmessar Biotech & Nutrition Share Price

Emmessar Biotech & Nutrition

CMP as on04-Aug-21 15:16

₹ 45.45
-2.35 -4.92%

Open

₹ 45.45

Turnover (lac)

₹ 1

Prev. Close

₹ 47.80

Day's Vol (shares)

₹ 3,276

Day's Range

₹ 45.45
₹ 45.45

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 19-Jul-2021 - -
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2021 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended 30.06.2021, which will be subjected to Limited Review. To discuss any other matter as may be decided by the Board. Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the newspaper clippings regarding the intimation of Board Meeting, to be held on Thursday, July 29, 2021, published in The Free Press Journal in English and Navshakti in Marathi, dated 21-07-2021, are attached. You are kindly requested to take this on record. (As Per BSE Announcement dated on 22.07.2021) The Board of Directors of the Company at its meeting held today i.e., 29th July, 2021 through Video Conferencing has transacted the following business. The meeting began at 02.00 pm and concluded at 4.00pm. 1. The Board has considered and approved the Un-Audited Standalone quarterly financial results of the Company for the first quarter ended June 30, 2021. The Results will be made available on the website of the Company: http://www.ebnl.org, in due compliance with the Listing Regulations. 2. The Board decided to convene the 29th Annual General Meeting on Wednesday, September 15, 2021. The intimation of the same to the BSE and Investors will be given shortly. 3. General discussion about other matters as per the agenda of the meeting. You are kindly requested to take this on record Emmessar Biotech & Nutrition Ltd has informed BSE regarding Outcome of Board Meeting held on July 29, 2021.. (As Per BSE Announcement Dated 29.07.2021)
Board Meeting - 12-May-2021 - -
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2021 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter / year ended March 31, 2021 and closure of Trading Window till expiry of 48 hours after declaration of Audited Financial Results as intimated earlier vide letter dated March 31, 2021. The Board of Directors of the Company at its meeting held today i.e., 21st May, 2021 has transacted the following business. 1. The Board has considered and approved the Audited Standalone financial results of the Company for the fourth quarter and financial year ended March 31, 2021. The Audited Financial Results of the Company for the quarter and year ended March 31, 2021 will be made available on the website of the Company: http://www.ebnl.org, in due compliance with the Listing Regulations. 2. The Board took on record the Auditors Report issued by the Statutory Auditors for the Audited Standalone Financial Result of the Company for the Financial Year 2020 - 2021. 3. Declaration pursuant to Regulation 33 (3) (d) of SEBI [LODR] Regulations, 2015. 4. The Board also decided to hold the Annual General Meeting, the date of which will be declared shortly. (As Per BSE Announcement Dated on 21/05/2021)
Board Meeting - 28-Jan-2021 - -
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2021 ,inter alia, to consider and approve the Un-Audited Financial Results for the Quarter and Nine months ended December 31, 2020. Please find attached the Un-Audited Financial Results for the Quarter ended December 31, 2020 alongwith the Limited Review. Kindly take the same in your records. (As per BSE Announcement Dated on 6/2/2021)
Board Meeting - 04-Dec-2020 - -
With reference to the above subject, we would like to inform you that on the recommendation of Nomination and Remuneration Committee of the Company, the Board of Directors of the Company in its meeting held on December 03, 2020, have approved the appointment of Mrs. Priyanka Sharma [CS Membership No. A52518], as Company Secretary of the Company w.e.f. December 12, 2020. In terms of Regulation 30 of the SEBI [LODR] Regulations, 2015 read with Circular No. CIR/CFD/CMD/4/20L5 dated 09.09.2015, brief profile of Mrs. Priyanka Sharma is enclosed herewith.
Board Meeting - 28-Oct-2020 - -
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended 30.09.2020, subjected to Limited Review. The Un-Audited Financial Results of the Company will be published soon after the Board Meeting. Pursuant to Regulation 33 of SEBI [LODR] Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today, have inter alia approved the Un-Audited Financial Results of the Company for the quarter ended September 30, 2020. The Board has also appointed Mr. Anantharama Sethumani Subramanian [DIN No. 00004479], as Additional Independent Director, on the Board of Directors w.e.f. November 6, 2020. (As Per BSE Announcement dated on 06.11.2020) Pursuant to Regulation 30 of SEBI [LODR] Regulations, 2015, we wish to intimate that the Board of Directors in their meeting held on November 6, 2020, have appointed Mr. Anantharama Sethumani Subramanian [DIN No. 00004479] as Additional Independent Director, on the Board of the Directors of Emmessar Biotech & Nutrition Ltd, w.e.f. November 6, 2020. His Directorship is subject to be accepted by the Ministry of Company Affairs. (As Per BSE Announcement Dated on 23.11.2020)
Board Meeting - 01-Sep-2020 - -
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2020 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended 30.06.2020, on Thursday, September 10, 2020 at 2.00 PM. The Trading Window for dealing in the securities will remain closed for Directors/Officers, Key Management Personnel and Designated Persons of the Company from September 2, 2020 till 48 hours after the declaration of financial results i.e. up to September 12, 2020 (both days inclusive).
Open ZERO Brokerage Demat Account